Literature DB >> 31410510

[Relevance of stereotactic ablative radiotherapy in patients with systemic metastasis].

Carsten Nieder1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31410510     DOI： 10.1007/s00066-019-01505-x

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  5 in total

Review 1.  Local treatment of oligometastatic disease: current role.

Authors:  Moritz T Winkelmann; Stephan Clasen; Philippe L Pereira; Rüdiger Hoffmann
Journal:  Br J Radiol       Date:  2019-06-06       Impact factor: 3.039

Review 2.  Integrated molecular and clinical staging defines the spectrum of metastatic cancer.

Authors:  Sean P Pitroda; Ralph R Weichselbaum
Journal:  Nat Rev Clin Oncol       Date:  2019-09       Impact factor: 66.675

3.  Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial.

Authors:  David A Palma; Robert Olson; Stephen Harrow; Stewart Gaede; Alexander V Louie; Cornelis Haasbeek; Liam Mulroy; Michael Lock; George B Rodrigues; Brian P Yaremko; Devin Schellenberg; Belal Ahmad; Gwendolyn Griffioen; Sashendra Senthi; Anand Swaminath; Neil Kopek; Mitchell Liu; Karen Moore; Suzanne Currie; Glenn S Bauman; Andrew Warner; Suresh Senan
Journal:  Lancet       Date:  2019-04-11       Impact factor: 79.321

4.  Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study.

Authors:  Daniel R Gomez; Chad Tang; Jianjun Zhang; George R Blumenschein; Mike Hernandez; J Jack Lee; Rong Ye; David A Palma; Alexander V Louie; D Ross Camidge; Robert C Doebele; Ferdinandos Skoulidis; Laurie E Gaspar; James W Welsh; Don L Gibbons; Jose A Karam; Brian D Kavanagh; Anne S Tsao; Boris Sepesi; Stephen G Swisher; John V Heymach
Journal:  J Clin Oncol       Date:  2019-05-08       Impact factor: 44.544

5.  Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma-a multicenter analysis of the German working group "Stereotactic Radiotherapy".

Authors:  Juliane Hoerner-Rieber; Marciana Duma; Oliver Blanck; Guido Hildebrandt; Andrea Wittig; Fabian Lohaus; Michael Flentje; Frederick Mantel; Robert Krempien; Michael J Eble; Klaus Henning Kahl; Judit Boda-Heggemann; Stefan Rieken; Matthias Guckenberger
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.